Latest in Research & Development

Certified biobased resins bring sustainable lab filtration to Cytiva’s customers

Certified materials enable labs to choose more sustainable options without changing workflows or compromising performance

Find out more

Thermo Fisher Scientific highlights its new accelerator drug development solutions at CPHI Frankfurt 2025

The company has also announced a collaboration with OpenAI as well as a new digital toolbox, OSDPredict, which combines AI and machine learning models to predict formulation...
See more

Syngene International plans to add bioconjugation suite for end-to-end antibody-drug conjugates development

Bioconjugation capability will complement commercial payload, linker and monoclonal antibodies services

Cellarity unveils AI-driven framework for cell state-correcting drug discovery in the journal Science

Biotech innovator Cellarity publishes a breakthrough blueprint integrating multiomics and machine learning to accelerate discovery of complex disease therapies, alongside the release of three open-access single-cell datasets

Orion secures exclusive license to Abzena’s CHAb-designed oncology antibody

The deal strengthens Orion’s cancer R&D pipeline with a de-risked monoclonal antibody developed using Abzena’s proprietary Composite Human Antibody (CHAb) and AbZelectPRO platforms

GemPharmatech and MSK to enter antibody research collaboration

The Memorial Sloan Kettering Cancer Center (MSK) will use GemPharmatech's antibody discovery platform to accelerate the development of next-generation cancer therapies

Immusoft receives FDA Fast Track Designation for ISP-001, a first-in-class engineered B cell therapy for MPS I

Immusoft’s ISP-001, designed to deliver continuous enzyme production through engineered B cells, becomes the first clinical-stage therapy of its kind to receive FDA Fast Track designation

MoonLake Immunotherapeutics faces Securities Class Action after disastrous Phase III trial results

The announcement about the trial results for the product candidate sonelokimab, a highly anticipated treatment for patients with skin disease, saw MoonLake investors' shares fall by about 90%, prompting an investigation into whether or not they were misled

Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours

The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio

Aseptic spray drying: Transforming biotherapeutics for a new era

With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications

Latest posts in Research & Development

AlzeCure Pharma publishes response letter clarifying Alzstatin’s distinct mechanism in Alzheimer’s treatment

AlzeCure Pharma and leading academic collaborators have published a response in JPET addressing recent commentary on Alzstatin’s γ-secretase modulation data, reaffirming the promise of lead candidate ACD680 in Alzheimer’s therapy

Amphista Therapeutics nominates first clinical candidate AMX-883, a novel Targeted Glue degrader for acute myeloid leukaemia

AMX-883, an orally available BRD9 degrader developed using Amphista’s Eclipsys platform, shows potent preclinical efficacy and a distinct DCAF16-based mechanism of action, paving the way for first-in-human trials in 2026

Quotient Sciences and Biorasi join forces to advance clinical trial solutions

The strategic partnership will deliver fully integrated early-phase clinical trial solutions, giving customers a simplified, efficient pathway from Investigational New Drug to proof-of-concept

Pharma leaders must separate AI hype from actionable opportunity, warns NIRAS

A new report from the company urges pharmaceutical executives to approach AI adoption with trust, transparency and traceability, outlining how the technology can drive compliance and productivity whilst warning against risks from poor data quality and opaque models

Celerion earns five-year AAHRPP reaccreditation, reinforcing leadership in ethical clinical research

Celerion becomes the only US-headquartered CRO to hold the distinction, underscoring its long-standing commitment to participant safety and research integrity

UK and Japan biotech associations sign MoU to strengthen life sciences collaboration

The UK BioIndustry Association and Japan Bioindustry Association have signed a Memorandum of Understanding to connect the two nations’ biotech ecosystems, promoting joint innovation, trade and the development of new biotechnologies

Harness Therapeutics and Ovo Venture Investment team up to launch R&D programme for rare neurodegenerative disorder

Harness Therapeutics unveils its second-generation MISBA Duo platform and kicks off a new R&D collaboration with Ono Venture Investment aimed at developing disease-modifying therapies for an undisclosed rare triplet repeat disorder

Intertronics releases white paper on process validation for medical device bonding

The new guidance helps manufacturers cut costs, save time and ensure ISO and FDA compliance by designing out variability and improving process reliability from the start

FDA lifts clinical hold on Neurizon’s NUZ-001 for ALS trial entry

The decision clears the path for NUZ-001 to join the HEALEY ALS Platform Trial later this year, advancing Neurizon’s lead therapy for amyotrophic lateral sclerosis and strengthening its regulatory and development pipeline
You need to be a subscriber to read this article.
Click here to find out more.

Building resilient outsourcing strategies: safeguarding oncology research samples against disaster risk (part II)

Part II of this article focuses on defining what “good” looks like in biorepository infrastructure, validation and documentation, providing practical guidance to create resilient, compliant storage solutions that underpin successful oncology research

Daiichi Sankyo launches third global research institute in San Diego

The company expands its international research footprint with a new San Diego institute, strengthening collaborations in one of the world’s leading life-science hubs and advancing its global drug discovery strategy

Sponsor content

Shimadzu launches ALTRACE energy dispersive X-ray fluorescence spectrometer

High-sensitivity analysis and automated measurements for food, environmental, and pharmaceutical inspections

Accelerating self-administration and homecare with large-volume prefillable glass syringe

SCHOTT Pharma launches 5.5 ml syringe compatible with autoinjectors to enable comfortable home injections

Aenova expands sterile fill & finish manufacturing at its Latina site

New line to boost biologics capacity and support a wide range of container formats

Sheffield University’s Energy Innovation Centre advances sustainable aviation

Precision Anton Paar instruments support cutting-edge SAF research

Abzena advances immunogenicity risk assessment in biologic drug development

New white paper explores how early testing helps predict and prevent unwanted immune responses in therapeutic proteins

Optimised fittings for microfluidic systems

Miniature flat-bottom ports combine convenience and performance for precise fluid control

Piramal Pharma Solutions awards Riverview and Digwal for patient centricity

Two sites recognised for innovative initiatives that put patients first

FDA US agent services backed by regulatory expertise

Helping medical device companies achieve smooth US market entry

What to expect from a regulatory inspection

NSF’s expert guide outlines key expectations, common pitfalls and strategies for lasting inspection readiness

IMA showcases innovation in processing and packaging at CPHI Frankfurt 2025

From gloveless filling to continuous manufacturing, IMA presents next-generation pharma and medtech solutions

Pharma Partnering US Summit 20225 is all set to commence in Boston on 13–14 November 2025

This high-impact conference brings together top executives from pharma, biotech, investment firms, and advisory groups for two dynamic days of deal-making, networking, and...

Almac invests $48 million to advance integrated eClinical technologies

New platform unifies trial operations, data, and systems to streamline complex clinical studies

Featured companies

Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life... The Almac Group is an established contract development and manufacturing organisation which provides an extensive range of integrated services to the pharmaceutical and biotech...
See more